Gereon Nelles
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Effectiveness of a digital health application (levidex) on quality of life in people with multiple sclerosis: A pragmatic, randomized controlled trial (LAMONT).
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: February 24, 2026
Relationship Between Endothelial Function, Vital Parameters, and Cognitive Performance in Community Dwellers with Subjective Cognitive Decline: An Observational Study with Six Months Follow Up.
Journal: Journal of Alzheimer's disease : JAD
Published: August 16, 2024
Long-Term Effects of the Multicomponent Program BrainProtect® on Cognitive Function: One-Year Follow-Up in Healthy Adults.
Journal: Journal of Alzheimer's disease reports
Published: December 23, 2023
Effects of the Multicomponent Cognitive Training Program BrainProtect in Cognitively Healthy Adults: A Randomized Controlled Trial.
Journal: Journal of Alzheimer's disease : JAD
Published: July 02, 2023
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: May 24, 2023
Influence of a 12-Month Structured Exercise Program on the Micronutrient-Cognitive Fitness-Physical Association Profiles in Mild Cognitive Impairment.
Journal: Journal of Alzheimer's disease reports
Published: June 21, 2022
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis.
Journal: Neurological research and practice
Published: May 27, 2022
A Stepped Health Services Intervention to Improve Care for Mental and Neurological Diseases: Protocol for a Prospective Cohort Trial.
Journal: JMIR research protocols
Published: February 25, 2022
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol.
Journal: BMJ open
Published: January 26, 2022
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: Interim results from the Plegridy Observational Program.
Journal: Multiple sclerosis and related disorders
Published: July 07, 2021
Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN.
Journal: Therapeutic advances in neurological disorders
Published: December 21, 2017
Last Updated: 09/26/2026